title: Antimicrobial resistance surveillance in the AFHSC-GEIS network.
abstract: International infectious disease surveillance has been conducted by the United States (U.S.) Department of Defense (DoD) for many years and has been consolidated within the Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) since 1998. This includes activities that monitor the presence of antimicrobial resistance among pathogens. AFHSC-GEIS partners work within DoD military treatment facilities and collaborate with host-nation civilian and military clinics, hospitals and university systems. The goals of these activities are to foster military force health protection and medical diplomacy. Surveillance activities include both community-acquired and health care-associated infections and have promoted the development of surveillance networks, centers of excellence and referral laboratories. Information technology applications have been utilized increasingly to aid in DoD-wide global surveillance for diseases significant to force health protection and global public health. This section documents the accomplishments and activities of the network through AFHSC-GEIS partners in 2009.
authors.affiliation: Armed Forces Health Surveillance Center, 11800 Tech Rd, Silver Spring, MD 20904, USA. william.meyer6@us.army.mil
authors.forename: William G
authors.initials: WG
authors.lastname: Meyer
authors.forename: Julie A
authors.initials: JA
authors.lastname: Pavlin
authors.forename: Duane
authors.initials: D
authors.lastname: Hospenthal
authors.forename: Clinton K
authors.initials: CK
authors.lastname: Murray
authors.forename: Kurt
authors.initials: K
authors.lastname: Jerke
authors.forename: Anthony
authors.initials: A
authors.lastname: Hawksworth
authors.forename: David
authors.initials: D
authors.lastname: Metzgar
authors.forename: Todd
authors.initials: T
authors.lastname: Myers
authors.forename: Douglas
authors.initials: D
authors.lastname: Walsh
authors.forename: Max
authors.initials: M
authors.lastname: Wu
authors.forename: Rosa
authors.initials: R
authors.lastname: Ergas
authors.forename: Uzo
authors.initials: U
authors.lastname: Chukwuma
authors.forename: Steven
authors.initials: S
authors.lastname: Tobias
authors.forename: John
authors.initials: J
authors.lastname: Klena
authors.forename: Isabelle
authors.initials: I
authors.lastname: Nakhla
authors.forename: Maha
authors.initials: M
authors.lastname: Talaat
authors.forename: Ryan
authors.initials: R
authors.lastname: Maves
authors.forename: Michael
authors.initials: M
authors.lastname: Ellis
authors.forename: Glenn
authors.initials: G
authors.lastname: Wortmann
authors.forename: David L
authors.initials: DL
authors.lastname: Blazes
authors.forename: Luther
authors.initials: L
authors.lastname: Lindler
mesh_terms: D003140:Communicable Disease Control; D021821:Communicable Diseases, Emerging / Q000453:epidemiology*; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D006801:Humans; D008887:Military Medicine; D008889:Military Personnel; D018571:Sentinel Surveillance; D014481:United States